“…As technologies advance, considerable amounts of strategies have been developed to overcome the difficulties brought by BBB, of which the mechanisms can be categorized as follows: receptor-mediated transcytosis (RMT: peptides and proteins) [ 10 , 11 ], adsorption-mediated transcytosis [ 12 ] (AMT), cell-mediated penetration [ 13 ], cellular barrier (lack of pinocytosis and bulk flow transcytosis), simple diffusion (CO 2 , O 2 , alcohol, lipophilic drugs < 400 Da and8 hydrogen bonds), CMT (carbohydrates, fatty, acids, monocarboxylic acids, amino acids, hormones, vitamins, organic anions and cations, and nucleotides) [ 14 ], major facilitators (ω 3 fatty acids), ions and water (Na + /H + ; Cl − /HCO 3 − ; Na + /K + /2Cl − ; Na + /Ca 2+ ), active efflux (ABC transporters, drugs, xenobiotic products, and drug conjugates), clearance of neurotoxic substances, diffusion of molecules across brain ECS and another physical or chemical process, such as cavitation effect from high intensity focused ultrasound (HIFU) [ 15 , 16 ]. Nanomaterials, with improved in vivo behaviors compared to small molecules, such as prolonged blood circulation time and enhanced accumulation in tumor sites, have been extensively explored to serve as nanoprobes for tumor imaging and therapy in the past decades [ 17 – 20 ]. The abundance of functional groups on the surface allows the conjugation of targeting molecules for RMT-mediated BBB crossing.…”